Godavari Biorefineries Limited (NSE:GODAVARIB)
271.90
+31.80 (13.24%)
Aug 11, 2026, 3:29 PM IST
Godavari Biorefineries Revenue
Godavari Biorefineries had revenue of 5.58B INR in the quarter ending June 30, 2026, with 4.62% growth. This brings the company's revenue in the last twelve months to 20.13B, up 7.00% year-over-year. In the fiscal year ending March 31, 2026, Godavari Biorefineries had annual revenue of 19.88B with 6.29% growth.
Revenue (ttm)
20.13B
Revenue Growth
+7.00%
P/S Ratio
0.70
Revenue / Employee
11.89M
Employees
1,692
Market Cap
14.00B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 19.88B | 1.18B | 6.29% |
| Mar 31, 2025 | 18.70B | 1.84B | 10.88% |
| Mar 31, 2024 | 16.87B | -3.28B | -16.28% |
| Mar 31, 2023 | 20.15B | 3.12B | 18.35% |
| Mar 31, 2022 | 17.02B | 1.64B | 10.67% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Chemplast Sanmar | 42.42B |
| GHCL Limited | 30.43B |
| Epigral | 26.26B |
| The Andhra Sugars | 24.66B |
| DCW Limited | 21.44B |
| Kanoria Chemicals & Industries | 9.81B |
| Sanstar | 7.85B |
| Sree Rayalaseema Hi-Strength Hypo | 6.67B |